CFTR and cystic fibrosis: Trials showed CF patients treated with CFTR modulators had improved lung function and decreased rates of pulmonary exacerbations, hospitalization, and IV antibiotic use, and the first studies on how these treatments impact respiratory microbiology in CF patients are now becoming available.